Geerts D - Search Results

1

Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene.

Schaaf G, Hamdi M, Zwijnenburg D, Lakeman A, Geerts D, Versteeg R, Kool M. Schaaf G, et al. Among authors: geerts d. Cancer Res. 2010 Jan 15;70(2):762-71. doi: 10.1158/0008-5472.CAN-09-2532. Epub 2010 Jan 12. Cancer Res. 2010. PMID: 20068162

2

The role of the MEIS homeobox genes in neuroblastoma.

Geerts D, Schilderink N, Jorritsma G, Versteeg R. Geerts D, et al. Cancer Lett. 2003 Jul 18;197(1-2):87-92. doi: 10.1016/s0304-3835(03)00087-9. Cancer Lett. 2003. PMID: 12880965 Review.

3

MEIS homeobox genes in neuroblastoma.

Geerts D, Revet I, Jorritsma G, Schilderink N, Versteeg R. Geerts D, et al. Cancer Lett. 2005 Oct 18;228(1-2):43-50. doi: 10.1016/j.canlet.2005.01.047. Cancer Lett. 2005. PMID: 15919149 Review.

4

Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines.

Henriksen JR, Løkke C, Hammerø M, Geerts D, Versteeg R, Flaegstad T, Einvik C. Henriksen JR, et al. Among authors: geerts d. Nucleic Acids Res. 2007;35(9):e67. doi: 10.1093/nar/gkm193. Epub 2007 Apr 10. Nucleic Acids Res. 2007. PMID: 17426119 Free PMC article.

5

Domain-wide regulation of gene expression in the human genome.

Gierman HJ, Indemans MH, Koster J, Goetze S, Seppen J, Geerts D, van Driel R, Versteeg R. Gierman HJ, et al. Among authors: geerts d. Genome Res. 2007 Sep;17(9):1286-95. doi: 10.1101/gr.6276007. Epub 2007 Aug 10. Genome Res. 2007. PMID: 17693573 Free PMC article.

6

Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation.

Geerts D, Wallick CJ, Koomoa DL, Koster J, Versteeg R, Go RC, Bachmann AS. Geerts D, et al. Clin Cancer Res. 2007 Nov 1;13(21):6312-9. doi: 10.1158/1078-0432.CCR-07-0829. Clin Cancer Res. 2007. PMID: 17975142

7

The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma.

Revet I, Huizenga G, Chan A, Koster J, Volckmann R, van Sluis P, Øra I, Versteeg R, Geerts D. Revet I, et al. Among authors: geerts d. Exp Cell Res. 2008 Feb 15;314(4):707-19. doi: 10.1016/j.yexcr.2007.12.008. Epub 2008 Jan 16. Exp Cell Res. 2008. PMID: 18201699

8

Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells.

Molenaar JJ, Ebus ME, Geerts D, Koster J, Lamers F, Valentijn LJ, Westerhout EM, Versteeg R, Caron HN. Molenaar JJ, et al. Among authors: geerts d. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12968-73. doi: 10.1073/pnas.0901418106. Epub 2009 Jun 12. Proc Natl Acad Sci U S A. 2009. PMID: 19525400 Free PMC article.

9

MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3.

Revet I, Huizenga G, Koster J, Volckmann R, van Sluis P, Versteeg R, Geerts D. Revet I, et al. Among authors: geerts d. Cancer Lett. 2010 Mar 28;289(2):195-207. doi: 10.1016/j.canlet.2009.08.019. Epub 2009 Oct 7. Cancer Lett. 2010. PMID: 19815336

10

The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification.

Geerts D, Koster J, Albert D, Koomoa DL, Feith DJ, Pegg AE, Volckmann R, Caron H, Versteeg R, Bachmann AS. Geerts D, et al. Int J Cancer. 2010 May 1;126(9):2012-24. doi: 10.1002/ijc.25074. Int J Cancer. 2010. PMID: 19960435 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters